🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

DANYELZA

Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.

Tags: DANYELZA, antibody, biopharmaceutical, cancer treatment, clinical trials

Website

About | About | ESG | Leadership | Directors | About | Contact | Contact | Careers

Symbol: YMAB

Recent Price: $7.76

Industry: Biotechnology

CEO: Mr. Michael Rossi

Sector: Healthcare

Employees: 100

Address: 230 Park Avenue, New York, NY 10169

Phone: 646 885 8505

Leadership

  • Michael Rossi, President and Chief Executive Officer
  • Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
  • Torben Lund-Hansen, SVP, Chief Technical Officer
  • Peter Pfreundschuh, Chief Financial Officer
  • Vignesh Rajah, SVP, Chief Medical Officer
  • Joris Wilms, SVP, Chief Operating Officer
  • Sue Smith, SVP, Chief Commercial Officer
  • Norman LaFrance, Chief Development Officer
  • Johan Wedell-Wedellsborg, Chairman
  • Ashutosh Tyagi, M.D.,
  • James I. Healy, Chairman
  • David N. Gill,
  • Laura J. Hamill,
  • Mary Tagliaferri, M.D.,

Last updated: 2024-12-31